22nd Century Group Inc. (XXII)
1.76
-0.03 (-1.68%)
At close: Mar 04, 2025, 11:23 AM
No 1D chart data available
Bid | 1.75 |
Market Cap | 3.03M |
Revenue (ttm) | 3.52M |
Net Income (ttm) | -5.08M |
EPS (ttm) | -2419.2 |
PE Ratio (ttm) | n/a |
Forward PE | -0.29 |
Analyst | n/a |
Ask | 1.78 |
Volume | 29,133 |
Avg. Volume (20D) | 986,731 |
Open | 1.79 |
Previous Close | 1.79 |
Day's Range | 1.73 - 1.79 |
52-Week Range | 1.68 - 581.85 |
Beta | 1.67 |
About XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collabo...
Industry Tobacco
Sector Consumer Defensive
IPO Date Jan 26, 2011
Employees 64
Stock Exchange NASDAQ
Ticker Symbol XXII
Website https://www.xxiicentury.com
1 month ago
-1.4%
22nd Century Group shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+21.57%
22nd Century Group shares are trading higher after the FDA announced it proposed significant step towards reducing nicotine to minimally or nonaddictive level in cigarettes and other combusted tobacco products.

2 months ago · newsfilecorp.com
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in CigarettesRecent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden Administration Mocksville, North Carolina--(Newsfile Corp. - December...